Pettinger W A, Lee H C, Reisch J, Mitchell H C
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
Hypertension. 1989 Jun;13(6 Pt 2):766-72. doi: 10.1161/01.hyp.13.6.766.
Seventy-nine hypertensive nephrosclerosis patients entered a prospective randomized single-blind study to 1) establish the pattern of decay of renal function in this population and the variability therein and 2) to determine if strict diastolic blood pressure (DBP) control (less than or equal to 80 mm Hg) is more effective than conventional levels (90-95 mm Hg) in conserving renal function. Because of unexpected significant improvement in renal function in patients from both groups, which changed the perspectives on the course of this disease as described herein, this report is being published before completion of the trial. The selection criteria were 1) serum creatinine concentration of 1.6-7.0 mg/dl, 2) glomerular filtration rate of less than 70 ml/min/1.73 m2, and 3) absence of diseases (other than hypertension) known to destroy renal function. Renal function was assessed by glomerular filtration rate [( 125I]iothalamate clearance) and serum creatinine concentration. Before randomization, DBP was aggressively treated to reduce it to less than 80 mm Hg. Twenty-two subjects (14 in the strict DBP control group and eight in the conventional DBP control group) have been enrolled in the study for 36 months. In contrast to results from previous studies in humans and rats, renal function improved in both patient groups. Thus, irrevocable progression of renal damage after onset of renal failure from high blood pressure does not necessarily occur, and in fact, long-term improvement of renal function resulted from the effects of the study itself.(ABSTRACT TRUNCATED AT 250 WORDS)
79名高血压肾硬化患者参与了一项前瞻性随机单盲研究,目的是:1)确定该人群肾功能衰退模式及其变异性;2)确定严格控制舒张压(DBP)(小于或等于80mmHg)在保护肾功能方面是否比传统水平(90 - 95mmHg)更有效。由于两组患者的肾功能均出现意外的显著改善,这改变了本文所述疾病进程的观点,因此本报告在试验完成前发表。入选标准为:1)血清肌酐浓度为1.6 - 7.0mg/dl;2)肾小球滤过率小于70ml/min/1.73m²;3)无已知会破坏肾功能的疾病(高血压除外)。通过肾小球滤过率([¹²⁵I]碘肽酸盐清除率)和血清肌酐浓度评估肾功能。在随机分组前,积极治疗DBP以将其降至80mmHg以下。22名受试者(严格DBP控制组14名,传统DBP控制组8名)已参与该研究36个月。与之前人类和大鼠研究的结果相反,两组患者的肾功能均有所改善。因此,高血压导致肾衰竭后肾损伤不一定会不可逆转地进展,事实上,研究本身的效应带来了肾功能的长期改善。(摘要截短至250字)